PHARMACOPEIA, INC.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 09, 2014 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,092 Total Citation Count
- Jun 07, 1995 Earliest Filing
- 37 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8017616 Heterocyclic substituted pyridine compounds with CXCR3 antagonist activityDec 21, 09Sep 13, 11[A61K, C07D]
7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disordersMar 09, 07May 31, 11[A61K, C07D, A61P]
7902199 Heterocyclic substituted piperazine compounds with CXCR3 antagonist activityJul 12, 07Mar 08, 11[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8501747 Functionally selective alpha2C adrenoreceptor agonistsExpiredFeb 11, 08Aug 06, 13[A61K, C07D]
8003624 Functionally selective ALPHA2C adrenoreceptor agonistsExpiredFeb 13, 07Aug 23, 11[A01N, C07D]
7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsExpiredJan 09, 07Apr 06, 10[A61K, C07D]
7511049 Pyrazolopyrimidines as cyclin dependent kinase inhibitorsExpiredJul 17, 07Mar 31, 09[A61K, C07D, A61P]
2009/0005,568 Substituted 2-aminothiazoles for treating neurodegenerative diseasesAbandonedAug 18, 06Jan 01, 09[A61K, C07D, A61P]
2008/0045,489 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDSAbandonedJul 05, 07Feb 21, 08[A61K, C07D, A61P]
2007/0054,925 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitorsAbandonedMar 31, 06Mar 08, 07[A61K, C07D]
6903131 3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsExpiredOct 11, 02Jun 07, 05[A61K, C07D]
6806056 Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agentExpiredApr 18, 02Oct 19, 04[G01N]
2004/0186,142 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsAbandonedOct 07, 03Sep 23, 04[A61K, C07D]
2003/0204,085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsAbandonedJul 30, 02Oct 30, 03[C07D, C07C]
2003/0139,435 N-heterocyclic inhibitors of TNF-alpha expressionAbandonedJun 26, 02Jul 24, 03[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.